Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results

PURPOSE: To report the long-term clinical outcomes after switching from intravitreal bevacizumab or ranibizumab to aflibercept therapy in eyes with AMD. METHODS: Retrospective analysis of changes in BCVA, SD-OCT image, and frequency of injections after 1, 2, and 3 years of follow-up. RESULTS: 164 ey...

Descripción completa

Detalles Bibliográficos
Autores principales: Neves Cardoso, Pedro, Pinheiro, Ana Fernanda, Meira, Jorge, Pedrosa, Ana Catarina, Falcão, Manuel S., Pinheiro-Costa, João, Falcão-Reis, Fernando, Carneiro, Ângela M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671733/
https://www.ncbi.nlm.nih.gov/pubmed/29201458
http://dx.doi.org/10.1155/2017/6835782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671733/
https://www.ncbi.nlm.nih.gov/pubmed/29201458
http://dx.doi.org/10.1155/2017/6835782

Ejemplares similares